Zura Bio Limited
NASDAQ Capital MarketTotal Valuation
Zura Bio Limited carries a market capitalization of 591.84M, placing it among publicly traded companies globally.
| Market Cap | 591.84M |
| Enterprise Value | N/A |
Share Statistics
Zura Bio Limited currently has 94.88M shares outstanding.
| Shares Outstanding | 94.88M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 2.60 |
| P/TBV Ratio | 2.60 |
| P/FCF Ratio | -8.23 |
| P/OCF Ratio | -8.22 |
Financial Position
Zura Bio Limited maintains a current ratio of 19.33, meaning it holds 19.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 19.33 |
| Quick Ratio | 19.21 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -42.48 |
| Return on Assets (ROA) | -37.61 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Zura Bio Limited's stock has gained approximately 200.96618% over the past 52 weeks. The 50-day moving average sits at 5.54, while the 200-day moving average is 5.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | 200.96618% |
| 50-Day Moving Average | 5.54 |
| 200-Day Moving Average | 5.23 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -81.43M, while operating income came in at -81.49M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -81.49M |
| Pretax Income | -75.43M |
| Net Income | -75.43M |
| EBITDA | -81.43M |
| EBIT | -81.49M |
| Earnings Per Share (EPS) | -0.75 |
Balance Sheet
Total book value stands at 216.90M, with working capital of 215.26M providing operational flexibility.
| Cash & Cash Equivalents | 225.59M |
| Total Debt | N/A |
| Net Debt | -225.59M |
| Equity (Book Value) | 216.90M |
| Book Value Per Share | 2.29 |
| Working Capital | 215.26M |
Cash Flow
Zura Bio Limited produced -72.67M in operating cash flow over the past twelve months. After subtracting -77,000.00 in capital expenditures, free cash flow totaled -72.75M - equivalent to -0.72 per share.
| Operating Cash Flow | -72.67M |
| Capital Expenditures | -77,000.00 |
| Free Cash Flow | -72.75M |
| FCF Per Share | -0.72 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -22.63 |
| FCF Yield | -12.16 |
Scores
Zura Bio Limited posts an Altman Z-Score of 27.27, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 27.27 |